Rise in Hospital Fungal Infections Reported Across Europe

The alarming increase in cases of the invasive fungal pathogen Candidozyma auris has been documented in European hospitals, prompting health authorities to take urgent action. According to a recent report by the European Centre for Disease Prevention and Control (ECDC), Germany ranked fifth in the number of reported infections between 2013 and 2023, following Spain, Greece, Italy, and Romania.

Candidozyma auris, previously known as Candida auris, is a yeast fungus that was first identified in Japan in 2009. Since its discovery, it has spread significantly across various regions, particularly within healthcare settings. This pathogen poses a serious risk as it exhibits resistance to multiple antifungal medications and can lead to severe infections in vulnerable patients.

The ECDC highlights the fungus's unique ability to survive on various surfaces and medical devices, facilitating transmission through contact. This characteristic complicates efforts to control its spread, as noted in the agency's findings.

The report reveals a dramatic surge in reported cases of Candidozyma auris within the EU and the European Economic Area, with over 4,000 cases logged from 2013 to 2023. Of these, 1,346 cases were reported in 2023 alone. Germany accounted for 120 cases during this period, with 77 occurring in the year 2023. The ECDC emphasizes that these figures likely represent only the 'tip of the iceberg' due to the lack of systematic reporting in many countries.

In response to this growing concern, the ECDC recommends that national health authorities implement robust measures for early detection, monitoring, and rapid intervention to curb the further spread of Candidozyma auris. Such actions could mitigate the impact of this pathogen on hospital patients across Europe.